Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Washington state lawmakers vote to overhaul medical pot industry

Published 04/15/2015, 01:08 AM
Updated 04/15/2015, 01:11 AM
Washington state lawmakers vote to overhaul medical pot industry

By Eric M. Johnson

SEATTLE (Reuters) - Washington state lawmakers passed a bill on Tuesday to regulate medical marijuana dispensaries running in parallel with recreational-use cannabis stores, in a first step towards reconciling the disjointed markets.

While marijuana remains illegal under federal law, voters in Washington state and Colorado sanctioned the recreational use of cannabis in landmark votes in 2012 that ushered in licensed and taxed retail stores offering adults a range of products.

But in Washington state, a loosely regulated medical marijuana industry runs alongside the recreational-use system, with retail business owners complaining they are at a disadvantage.

"Regulations on the market had to happen," said John Davis, who owns two medical dispensaries in Seattle. "Keeping a non-commercial and a commercial medical system open, ultimately, is going to serve the patients."

The Washington Senate on Tuesday voted 41-8 for the bill that will remove collective gardens, which supply medical dispensaries, from July 1 next year, in favor of four-person "cooperatives."

Some existing collectives can continue to run if granted a license on the basis of factors such as the applicant's tax history.

The bill will let state-licensed pot retailers obtain a medical marijuana endorsement to sell products.

It also creates a database of medical patients and lets authorized patients possess three times the amount of marijuana allowed by the recreational-use law. They can also grow up to six plants at home.

Washington Governor Jay Inslee, who has been pushing lawmakers to act on the issue for a year, is expected to sign the measure into law but can veto parts of it. A similar version of the bill passed the House last week.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Opponents have criticized the measure as the equivalent of a sick person having to get medicine in a liquor store, saying regulators were already "overtasked" in managing commercial pot, while patients feared higher retail prices.

Many unanswered questions remain, such as the number of dispensaries to survive under the bill and how actively police would clamp down on shops violating the law, besides the fate of another bill on the industry's tax structure.

Republican Senator Ann Rivers, the bill's sponsor, called the measure a "first step" in reconciling the two marijuana markets, saying: "I am certain we'll be back fine-tuning this next year."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.